Nfkbia Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
IκB Alpha (NFKBIA or IκBα) is a critical inhibitory protein that sequesters NF-κB transcription factors in the cytoplasm. As the primary inhibitor of NF-κB, IκBα plays a central role in regulating inflammatory responses and cell survival pathways. [1]
NFKBIA Protein is a protein involved in critical biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, mitochondrial maintenance, or stress response mechanisms that are essential for neuronal health. [2]
Dysregulation or mutations in this protein contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders through effects on protein function, inflammatory signaling, mitochondrial function, or cell survival pathways. [3]
--- [4]
IκBα is a 317 amino acid protein (approximately 37 kDa) belonging to the IκB family of inhibitory proteins. The protein contains: [5]
The ankyrin repeats mediate: [6]
IκBα functions as a molecular inhibitor of NF-κB: [7]
Mechanism:
Activation-induced degradation:
Feedback regulation:
NFKBIA is inducibly expressed:
Brain expression:
IκBα/NF-κB dysregulation is implicated in:
IκBα-based therapies:
IκBα knockout mice:
Transgenic IκBα:
Current research:
The study of Nfkbia Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
2 Hayden MS, Ghosh S. Shared principles in NF-κB signaling. 2008. ↩︎
3 Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. 1996. ↩︎
4 Mattson MP, Meffert MK. Roles for NF-κB in nerve cell survival, plasticity, and disease. 2006. ↩︎
5 Camandola S, Mattson MP. NF-κB as a therapeutic target in neurodegenerative diseases. 2007. ↩︎
6 Shih RH, Wang CY, Yang CM. NF-κB and its role in neuroinflammation. 2015. ↩︎
7 Kaltschmidt B, Kaltschmidt C. NF-κB in the nervous system. 2009. ↩︎
8 Chen J, et al. IκBα degradation in Alzheimer's disease. 2012. ↩︎